3-Hydroxyl-3-methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitor (Statin)-induced 28-kDa Interleukin-1β Interferes with Mature IL-1β Signaling
Open Access
- 1 June 2014
- journal article
- immunology
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (23) , 16214-16222
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1 R21 AI095871-01)
This publication has 45 references indexed in Scilit:
- Statins as potential therapeutic drug for asthma?Respiratory Research, 2012
- RIP3 mediates the embryonic lethality of caspase-8-deficient miceNature, 2011
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Multiple interleukin‐1β–converting enzymes contribute to inflammatory arthritisArthritis & Rheumatism, 2009
- AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCNature, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Trefoil Family Factor 2 Is Expressed in Murine Gastric and Immune Cells and Controls both Gastrointestinal Inflammation and Systemic Immune ResponsesInfection and Immunity, 2007
- Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic MechanismsNature Reviews Drug Discovery, 2005
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Regulation of the mevalonate pathwayNature, 1990